Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$0.38
-5.7%		$0.39
$0.35
▼
$1.19
$25.13M1.3962,960 shs51,679 shs
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
$0.27
+12.5%		$0.27
$0.15
▼
$0.54
$23.17M0.715,601 shs1,353 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.68
+0.4%		$0.75
$0.60
▼
$1.69
$25.90M1.2710,666 shs3,530 shs
PMI stock logo
PMI
PMI
$3.52
-0.3%		$11.44
$3.08
▼
$684.00
$7.25MN/A94,378 shs48,564 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.00%+11.08%+11.08%-16.51%-65.53%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
0.00%-17.24%-14.26%+20.00%-12.73%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00%+4.62%-11.52%-7.10%-16.16%
PMI stock logo
PMI
PMI
0.00%+2.92%-49.64%-58.79%+352,999,900.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$0.38
-5.7%		$0.39
$0.35
▼
$1.19
$25.13M1.3962,960 shs51,679 shs
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
$0.27
+12.5%		$0.27
$0.15
▼
$0.54
$23.17M0.715,601 shs1,353 shs
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$0.68
+0.4%		$0.75
$0.60
▼
$1.69
$25.90M1.2710,666 shs3,530 shs
PMI stock logo
PMI
PMI
$3.52
-0.3%		$11.44
$3.08
▼
$684.00
$7.25MN/A94,378 shs48,564 shs
7 Stocks That Will Be Magnificent in 2026 Cover
7 Stocks That Will Be Magnificent in 2026

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
0.00%+11.08%+11.08%-16.51%-65.53%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
0.00%-17.24%-14.26%+20.00%-12.73%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00%+4.62%-11.52%-7.10%-16.16%
PMI stock logo
PMI
PMI
0.00%+2.92%-49.64%-58.79%+352,999,900.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
2.00
Hold$5.381,324.97% Upside
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
0.00
N/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.00
N/AN/AN/A
PMI stock logo
PMI
PMI
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest PMI, GTHP, PETV, and CTSO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/6/2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/3/2026
PMI stock logo
PMI
PMI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
5/19/2026
PMI stock logo
PMI
PMI
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
5/18/2026
PMI stock logo
PMI
PMI
HC Wainwright logo
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral
(Data available from 8/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
$37.06M0.64N/AN/A$0.09 per share4.19
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
$770K33.85N/AN/A($0.09) per share-3.00
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
$1.05M24.76N/AN/A($0.03) per share-22.75
PMI stock logo
PMI
PMI
$4.94M1.46N/AN/A$2.57 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$8.20M-$0.29N/AN/AN/A-48.94%-431.65%-41.94%N/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
-$3.20M-$0.04N/AN/AN/AN/AN/A-243.93%N/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
-$10.95M-$0.34N/AN/AN/A-902.82%-4,813.07%-281.78%N/A
PMI stock logo
PMI
PMI
-$27MN/AN/AN/AN/A-531.21%N/A-197.02%N/A

Latest PMI, GTHP, PETV, and CTSO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2026Q2 2026
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
N/A-$0.01N/A-$0.01N/AN/A
8/6/2026Q2 2026
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
-$0.04-$0.07-$0.03-$0.07$9.39 million$9.63 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
N/AN/AN/AN/AN/A
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
N/AN/AN/AN/AN/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
N/AN/AN/AN/AN/A
PMI stock logo
PMI
PMI
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
4.70
0.66
0.50
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
N/A
0.09
N/A
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
0.02
0.42
0.47
PMI stock logo
PMI
PMI
0.01
0.75
0.16

Institutional Ownership

CompanyInstitutional Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
32.87%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
9.69%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
24.55%
PMI stock logo
PMI
PMI
N/A

Insider Ownership

CompanyInsider Ownership
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
7.80%
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
66.83%
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
10.84%
PMI stock logo
PMI
PMI
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytosorbents Corporation stock logo
CTSO
Cytosorbents
22062.84 million57.94 millionOptionable
Guided Therapeutics Inc. stock logo
GTHP
Guided Therapeutics
596.54 million32.02 millionNot Optionable
PetVivo Holdings, Inc. stock logo
PETV
PetVivo
2037.95 million19.06 millionNot Optionable
PMI stock logo
PMI
PMI
N/A2.05 millionN/AN/A

Recent News About These Companies

New York’s Factory Activity Expands to 4-Year Highs: Is AI Powering a Manufacturing Boom?
August 17 at 12:51 PM  |  benzinga.comhttps://www.benzinga.com/markets/tech/26/08/61254054/new-york-manufacturing-four-year-high-ai-boom
Steven Madden: Riding The Apparel PMI Rebound And Marketing Momentum
August 14 at 9:32 AM  |  seekingalpha.comhttps://seekingalpha.com/article/4936738-steven-madden-riding-the-apparel-pmi-rebound-and-marketing-momentum?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Economic calendar: flash manufacturing and services PMI
August 14 at 7:51 AM  |  marketwatch.comhttps://www.marketwatch.com/bulletins/redirect/go?g=c9787c3e-e841-4985-a310-d219be0b7063&mod=mw_rss_bulletins
PMI Rises
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934893-pmi-rises?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Global PMI Shows Inflation Rates Remaining Elevated Amid Rising Demand For Services
August 8, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4933741-global-pmi-shows-inflation-rates-remaining-elevated-amid-rising-demand-for-services?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Bitcoin price coils under $65K as US PMI data brings new ‘stagflation’ warning
August 6, 2026  |  cointelegraph.comhttps://cointelegraph.com/markets/bitcoin-price-compresses-as-us-pmi-data-brings-new-stagflation-warning?utm_source=rss_feed&utm_medium=feed&utm_campaign=rss_partner_inbound
Manufacturing PMI Hits 4-Year High: 3 Top Industrial Stocks
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931055-manufacturing-pmi-hits-4-year-high-3-top-industrial-stocks?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Global PMI Signals Faster Economic Growth As Equipment Spending Surges
August 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4931505-global-pmi-signals-faster-economic-growth-as-equipment-spending-surges?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Enact Reports $175 Million Q2 Net Income and Raises Capital Return Guidance
August 5, 2026  |  quiverquant.comQ
$LIVN stock is down 11% today. Here's what we see in our data.
August 5, 2026  |  quiverquant.comQ
U.S. Services Index Inches Slightly Higher In July
August 5, 2026  |  rttnews.comhttps://www.rttnews.com/3676103/u-s-services-index-inches-slightly-higher-in-july.aspx?type=ts
Economic calendar: ADP employment, U.S. services PMI, ISM services
August 5, 2026  |  marketwatch.comhttps://www.marketwatch.com/bulletins/redirect/go?g=6b699f4a-2699-489d-a3d7-abb890262b17&mod=mw_rss_bulletins
Global Market: UK stocks rise after services PMI signals economic recovery
August 5, 2026  |  economictimes.indiatimes.comhttps://economictimes.indiatimes.com/markets/us-stocks/news/global-market-uk-stocks-rise-after-services-pmi-signals-economic-recovery/articleshow/132912730.cms
Global PMI Data Point To Sustained Manufacturing Growth Spurt In July, But Momentum Slows Amid High Prices, Uncertainty And Reduced Stock Building
August 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4929786-global-pmi-data-point-to-sustained-manufacturing-growth-spurt-in-july-momentum-slows-amid-high-prices-uncertainty?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Dr. Copper Is Flashing An Economic Boom: Industrial Stocks Just Confirmed It
August 3, 2026  |  benzinga.comhttps://www.benzinga.com/markets/commodities/26/08/60880407/dr-copper-economic-boom-ism-pmi-four-year-high-fcx-copx-industrials
Crude Oil Tumbles 7%; ISM Manufacturing PMI Rises In July
August 3, 2026  |  benzinga.comhttps://www.benzinga.com/markets/market-summary/26/08/60879584/crude-oil-tumbles-7-ism-manufacturing-pmi-rises-in-july
U.S. Manufacturing Index Climbs To Four-Year High In July
August 3, 2026  |  rttnews.comhttps://www.rttnews.com/3674543/u-s-manufacturing-index-climbs-to-four-year-high-in-july.aspx?type=ts
Economic calendar: U.S. manufacturing PMI, then data on construction spending
August 3, 2026  |  marketwatch.comhttps://www.marketwatch.com/bulletins/redirect/go?g=74634e91-52a6-42dc-9e67-616994c40886&mod=mw_rss_bulletins
Pre-market action: Here's the trade setup for today's session
August 2, 2026  |  economictimes.indiatimes.comhttps://economictimes.indiatimes.com/markets/stocks/news/pre-market-action-heres-the-trade-setup-for-todays-session/articleshow/132809640.cms
Earnings, PMI and Other Key Things to Watch this Week
August 2, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/earnings-pmi-other-key-things-170002166.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cytosorbents stock logo

Cytosorbents NASDAQ:CTSO

$0.38 -0.02 (-5.68%)
As of 04:00 PM Eastern

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey.

Guided Therapeutics stock logo

Guided Therapeutics OTCMKTS:GTHP

$0.27 +0.03 (+12.50%)
As of 03:55 PM Eastern

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

PetVivo stock logo

PetVivo NASDAQ:PETV

$0.68 +0.00 (+0.37%)
As of 03:37 PM Eastern

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

PMI stock logo

PMI NYSEAMERICAN:PMI

$3.52 -0.01 (-0.28%)
As of 04:10 PM Eastern

Picard Medical Inc. is a medical technology company which manufactures and sells the only total artificial heart. Picard Medical Inc. is based in TUCSON, Ariz.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas